Mumbai Metro Yellow Line Route Map

Mumbai Metro Rail Corporation Limited (MMRCL) began the integrated trial of underground Metro Line-3 (Colaba-Bandra-SEEPZ) Phase 1 on March 12. This service will be made available to passengers after MMRCL gets approval from the Commissioner. After the trials are run, officials need to obtain certification from the individual system and Independent Safety Assessor (ISA). Then, the system will be presented to the Commissioner of Metro Railway Safety (CMRS) for inspection and approval.

Maharashtra Chief Minister Eknath Shinde on Sunday laid the foundation stone of Mumbai Metro Line-12 (Kalyan-Taloja) at the Premier Ground in Dombivali. Kalyan–Taloja section (Line-12) is an extension of Mumbai Metro Line 5, Orange Line. The extension will reduce travel time between Kalyan-Dombivli and Navi Mumbai.

The 22.173-kilometre stretch will have 19 elevated stations. The estimated cost of the completion of the project is around Rs 5,865 crore. The project is estimated to be complete by December 2027. According to an Indian Express report, the integration of Metro Line-12 with Navi Mumbai Metro Line is also proposed at Navi Mumbai Metro station to ensure smooth connectivity between Navi Mumbai and Kalyan-Dombivli.

To celebrate the glorious history of Indian cinema, a unique initiative has been launched to grace Mumbai Metro Line 2B running from Bandra West. Mumbai BJP president and MLA, Advocate Ashish Shelar unveiled a plan to transform the spaces between 355 pillars spanning seven stations from ESIC Nagar to Bandra into a vibrant tribute to Bollywood.

Mumbai's eagerly awaited underground metro Line 3, passing through the Colaba-Bandra-Seepz route, is set to be partially completed by the middle of this year. Mumbai Metro Rail Corporation (MMRC) managing director Ashwini Bhide told The Indian Express that they have completed 95 per cent, which includes building the tunnel from Aarey to BKC and construction of nine intermediate stations. He estimates that full connectivity will be achieved by February 15-20, allowing integrated trials to begin.